Pain treatment at the C.B.P.

Authors

  • Enrique Bzurovski

Keywords:

aa

Abstract

Pain is a frequent sympton often persistent and difficult to treat. It is caused by mediastinal or thoracic wall invasion where the Pancoast tumor is pointed out. The different pathogenic mechanisms are studied. When selecting the correct treatment the needs of working in a multidiscipline group is emphazised. A reasonable use of analgesic drugs is adviced as well as the ideal analgesic is defined. A progressive plan is suggested starting from very mild drugs to the very strong ones, trying to obtain the maximum benefits offered by each product. At the begining ASS will be administrated and it could be combined with paracetamol or codeine.
The next step is the prescription of sinthetic morfinomimetics: D-propoxifeno (Dioxadol) or Pentazocima (sosegón). If pain relief is not obtained, then these drugs will be substituted by narcotics. The disadvantages of the parenteral usage of these drugs are stressed.
The good results obtained with the morphine products for oral intake are emphazised. The different types and indications of nervous blockade is exposed. The advancements in pain relief are considerable and. one of them are the neurostimulators of very re centusage.

Downloads

Download data is not yet available.

Downloads

Published

1982-03-29

How to Cite

1.
Bzurovski E. Pain treatment at the C.B.P. Cir. Urug. [Internet]. 1982 Mar. 29 [cited 2026 May 24];52(2):148-50. Available from: https://replica-revista.scu.org.uy/index.php/cir_urug/article/view/3326

Issue

Vol. 52 No. 2 (1982): Cirugía del Uruguay

Section

Original Article

License

All articles, videos and images published in Revista Cirugía del Uruguay are under the Creative Commons CC licenses, which is a complement to the traditional copyright, in the following terms: first, the authorship of the referred document must always be acknowledged and secondly none of the article or work published in the journal may have commercial purposes of any nature. The authors retain their copyrights and give the magazine the right of first publication of their work, which will be simultaneously  subject to the Creative Commons Attribution-NonCommercial 4.0 International License license that allows the work to be shared whenever  the initial publication is indicated in this journal.